Skip to content
Government NSW, Medical Health Aged Care

***MEDIA ALERT*** Western Sydney demands a say in Drug Summit decision making

Uniting NSW.ACT < 1 mins read

Press Conference

Following a round table discussion, representatives of diverse communities from across western and south-western Sydney will hold a press conference today to discuss the experiences and needs of the people they represent when it comes to drug policy in NSW. 

 

Ahead of the Sydney based drug summit in December, they want to raise awareness of:

 

 

-The consequences of shame and stigma for people who use drugs in their communities
-The need for more culturally appropriate services and treatment options to save lives
-The impact of over-policing and negative interactions with the criminal justice system. 

Alex Hogan, Social Justice Lead at Uniting NSW.ACT said: “Premier Minns needs to hear what our diverse, multicultural communities are seeing and hearing on the ground around drug use and what outcomes they want from the Drug Summit." 

 

Who:

 

  • Alex Hogan - Uniting’s Fair Treatment campaign
  • Adam Ismail - The Rehabilitation Project
  • Hanan Dover - Hayat House  
  • Imam Mahmoud Alazhari – Australian National Imams Council

 

Where:

Parramatta Mission, 119 Macquarie Street, Parramatta

 

When:

10.30 am, Tuesday 19th November

 

Uniting NSW.ACT runs the Medically Supervised Injecting Centre and has spearheaded the Fair Treatment campaign for fairer drug laws for over five years. 

 

Media contacts: 
Sofie Wainwright - Horton Advisory 0403 920 301 

Bronwen Reed - Uniting Media 0481 056 714

 

About Uniting

Uniting NSW.ACT contributes to the work of the Uniting Church in NSW and the ACT, through social justice advocacy, community services and spiritual care. We provide services for people through all ages and stages of life, and drive solutions to systemic issues so people experiencing disadvantage can live their best lives. Our purpose is to inspire people, enliven communities and confront injustice. We value diversity and always welcome everyone exactly as they are.

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.